Literature DB >> 2537479

Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat.

J E Haley1, A H Dickenson, M Schachter.   

Abstract

Single nociceptive neurones were recorded in the L1-L3 region of the dorsal horn of the spinal cord in halothane anaesthetized intact rats. Subcutaneous formalin (50 microliters of 5% solution) into the peripheral receptive field produces a biphasic activation of these neurones. The initial 1st peak of the response was unaltered by any of the treatments. However, the prolonged 2nd peak of the response was significantly reduced to a similar degree by 10 min pretreatment with 50 micrograms subcutaneous B4162 (a bradykinin B2 receptor antagonist) and by prior desensitization of the receptive field with bradykinin. The putative bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin (DALB) applied subcutaneously (50 micrograms) 10 min prior to formalin had no effect on the subsequent responses to formalin implying that the B4162 and bradykinin desensitization effects occur via the B2 receptor. Repeated subcutaneous injection of bradykinin (10 microliters of a 1 mg/ml solution) was used to elicit responses in these dorsal horn neurones and these were shown to be antagonised by 50 micrograms B4162 suggesting that the effects of this compound on the formalin response are indeed due to its ability to inhibit bradykinin induced neuronal activity. These results provide electrophysiological evidence for a physiological role of bradykinin as a mediator in prolonged chemical nociception.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537479     DOI: 10.1016/0304-3940(89)90163-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.

Authors:  H Rogers; P J Birch; S M Harrison; E Palmer; G R Manchee; D B Judd; A Naylor; D I Scopes; A G Hayes
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.

Authors:  C R Corrêa; D J Kyle; S Chakraverty; J B Calixto
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

3.  Bradykinin-induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro.

Authors:  A Dray; I A Patel; M N Perkins; A Rueff
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

4.  Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.

Authors:  C R Corrêa; J B Calixto
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  B1 bradykinin receptors and sensory neurones.

Authors:  C L Davis; S Naeem; S B Phagoo; E A Campbell; L Urban; G M Burgess
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat.

Authors:  A J Davis; M N Perkins
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

7.  The role of prostaglandins in the bradykinin-induced activation of serosal afferents of the rat jejunum in vitro.

Authors:  K A Maubach; D Grundy
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

Review 8.  Pain management: physiopathology, future research and endpoints.

Authors:  M Sosnowski
Journal:  Support Care Cancer       Date:  1993-03       Impact factor: 3.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.